drugset / Trial / NCT03103919
Study to Evaluate the Impact of Using Wearable Devices in Addition to Standard Clinical Practice on Parkinson´s Subject Symptoms Management
RandomizedParallel-groupOpen-labelTreatment
Summary
Evaluate the benefits of Kinesia-360™ wearable technology in addition to standard clinical practice on improving Parkinson´s disease motor symptoms, Neupro dosing regimen and adherence to Neupro compared with only standard clinical practice.
Timeline
- Start
- 2017-03-16
- Primary completion
- 2018-01-02
- Completion
- 2018-01-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rotigotine | Unknown | 2 mg | — |
| Subject | Rotigotine | Unknown | 4 mg | — |